Pharmaceutical Market 2021

The author of the report analyzed that the global pharmaceutical market accounted for US$ 1350.29 billion in 2017. Chronic conditions such as diabetes, depression, asthma and hypertension are increasing. The companies use FDA-regulated information to inform physicians and patients about new medicines in advance of a prescribing decision. Direct-to-consumer advertising also help in increasing the demand for a particular drug.

Growth opportunities for pharma companies are expected to increase in next few years, as many drugs are going off-patent in the US and other countries, which is increasing competition. Digital Health Knowledge Resources, Electronic Medical Record, Mobile Healthcare, Electronic Health Record, Hospital Information System and PRACTO are some of the technologies gaining wide acceptance in the sector. Pharmaceutical market is facing unprecedented challenges caused by slower sales growth, shorter product life cycles, tighter regulations, expiring patents, increasing competition from generics, adverse media coverage and reputational damage, and a decline in the number of new innovative drugs under development. However, due to increasing population and income levels, demand for high-end drugs is expected to rise.

Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Pharmaceutical-Market-2018-2026-33

Major Key Players:

Some of the key participants in global market are Abbott, AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Baxter, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc, Merck & Co., Inc, Novartis AG, Pfizer, Inc., Sanofi and Teva Pharmaceutical Industries Ltd.

Key findings of the report:

Among the drug type, prescription drug is a dominant segment holding the largest market share. Existence of government-protected “monopoly” rights for drug manufacturers is driving the prescription drugs. In 2015, the US pharmaceutical industry spent $5.2 billion on advertising prescription drugs directly to consumers.

This sector is characterized by an extensive Research and Development (R&D) infrastructure and a comprehensive talent pool. It has an appropriate scientific regulatory system, and an advanced environment for fostering investments in new drug discovery and development. In the United States, R&D investments of the companies have grown consistently over the past 15 years. The U.S. pharmaceutical market is the world’s most important national market with a number of top global companies from the United States.

Market Segmentation

Pharmaceutical Market – By API Type

Synthetic API

Biotech API

Pharmaceutical Market – By Drug Type

Prescription Drugs

OTC Drugs

Market By Customer Base Type

Generic Drugs

Branded Drugs

Pharmaceutical Market – By Application Type

Oncology

Cardiovascular Disease

Diabetes

Central Nervous System and Neurological Disorders

Endocrinology

Gastrointestinal Disorders

Nephrology

Ophthalmology

Others

Market By Region

North America

U.S.

Rest of North America

Europe

France

The UK

Spain

Germany

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Southeast Asia

Rest of Asia Pacific

Middle East and Africa

GCC Countries

Southern Africa

Rest of Middle East and Africa

Latin America

Brazil

Rest of Latin America

Contact us:

Shreyas Tanna

Phone: +91-740-024-2424

Absolute Markets Insights

Email: [email protected]